OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« Apotex Tries Again for DJ Jurisdiction Based on Patent Listing in Orange Book | Main | Pfizer Wins Another Round in Norvasc Case as Synthon's Patents Are Found Unenforceable »

February 01, 2007

Senators Reintroduce Bill to Ban Authorized Generics

Senator Jay Rockefeller (D-WV) has introduced S. 438, "The Fair Prescription Drug Act of 2007," which would ban the sale of authorized generic drugs during an ANDA applicant's 180-day exclusivity period.  The bill is cosponsored by Senators Kohl (D-WI), Leahy, (D-VT), and Schumer (D-NY).  The same bill was proposed last year as S. 3695.  Senator Kohl expressed optimism that the bill would have better prospects this time around--and it just might, given that the Democrats now control Congress.

RELATED READING:

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.